LINDSEY SIMMONS: Open Payments
NPI 1447794789 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,688 in 89 payments from 17 companies in 2025. Trend: 2023 $421 · 2024 $1,899 · 2025 $1,688
Food & beverage: $1,688
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $295 |
| Novo Nordisk Inc | 15 | $285 |
| PFIZER INC. | 13 | $238 |
| AstraZeneca Pharmaceuticals LP | 11 | $191 |
| Lilly USA, LLC | 7 | $142 |
| Dexcom, Inc. | 5 | $118 |
| Phathom Pharmaceuticals, Inc. | 5 | $95 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
Products named: NURTEC ODT, Wegovy, VRAYLAR, QULIPTA, Dexcom G6 Transmitter, FARXIGA, MOUNJARO, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
